COVID-19

UK government strengthen their pandemic preparedness with H5 influenza vaccine

In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.

More must be done to tackle diabetes

Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.

Five new research projects will examine COVID-19 vaccine responses

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.

Immunocompromised patients show low immune response after second vaccine

According to the OCTAVE study, immunocompromised patients presented low immune responses after two doses of the same COVID-19 vaccine.

Clinical trial to test third COVID-19 vaccine for people with weakened immune systems

A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.

UK orders 35 million more Pfizer/BioNTech vaccine doses

The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..

The Green Post COVID Era: Sustainable IT for the future

Walter Heck, CTO at HeleCloud, looks ahead to the Green Post COVID Era and argues that sustainable IT paves the way for a green future.

Has COVID-19 made mental health at work impossible to ignore?

Jorge E Palacios, MD, PhD, Senior Digital Health Scientist at SilverCloud Health, argues that the pandemic has made mental health in the workplace impossible to ignore.

We’re in a race on climate and major cities are leading

Angie Fyfe, Executive Director of ICLEI – Local Governments for Sustainability USA, discusses how thousands of stakeholders are mobilising ahead of COP26.

NHS GP says long COVID patients “shouldn’t suffer in silence”

NHS GP and lead GP at Numan, Dr Luke Pratsides tells us everything he knows about the symptoms of long COVID and what’s being done to tackle this novel disease.

Climate change & the great humanitarian challenges

Climate change is behind all of the great humanitarian challenges. We must do more to combat it, argues Aamir Mumtaz, Water, Sanitation and Hygiene Programme Manager at Human Appeal Pakistan.

COVID-19: Challenges of vaccination logistics

The challenges of vaccination logistics during the COVID-19 pandemic are charted in this updated view, written by Zisis Kozlakidis and John Litaker.

The risks of using alcohol-based hand sanitiser

Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the risks of using alcohol-based hand sanitiser.

The EU needs a new Marshall Plan for oncology

Małgorzata Anna Bogusz, Rapporteur of the EESC opinion SOC/677 – Europe’s beating cancer plan, argues here that the EU needs a new Marshall Plan for oncology.

How data shielded our most vulnerable during the pandemic

Mark Reynolds, Chief Technology Officer at NHS Digital, talks about the unique challenges brought about by the pandemic, and how using data innovatively with the Shielded Patient List and Population Risk Assessment helped to identify and protect some of the most vulnerable in society.

Taking back control to combat COVID misconceptions 

Francesca Gargaglia, COO and CBO, Amity, argues that although social media platforms should be responsible for preventing the spread of COVID-19 misinformation, government agencies should build their own communities that build trust and promote well-informed discussions.

Campaigners call for approval of life saving COVID-19 antibody treatments

A group of patient bodies, charities and senior clinicians have urged the Government to approve the use of life-saving COVID-19 antibody treatments.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders